Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-11 MICEK JOHN Director Grant or award +7,377 7,430
2025-12-11 MICEK JOHN Director Grant or award · Stock Option (right to buy) +7,377 7,377
2025-12-11 King Steven R. See Remarks Grant or award +11,740 11,885
2025-12-11 King Steven R. See Remarks Grant or award · Stock Option (right to buy) +11,740 11,740
2025-12-11 Wolin Jonathan S. See Remarks Grant or award +11,740 11,938
2025-12-11 Wolin Jonathan S. See Remarks Grant or award · Stock Option (right to buy) +11,740 11,740
2025-12-11 CONTE LISA A See Remarks Grant or award +28,592 29,258
2025-12-11 CONTE LISA A See Remarks Grant or award · Stock Option (right to buy) +28,592 28,592
2025-12-11 Chaturvedi Pravin R Chief Scientific Officer Grant or award +11,740 11,938
2025-12-11 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Stock Option (right to buy) +11,740 11,740
2025-12-11 BOCHNOWSKI JAMES J Director Grant or award +6,363 6,415
2025-12-11 BOCHNOWSKI JAMES J Director Grant or award · Stock Option (right to buy) +6,363 6,363
2025-12-11 Siegel Jonathan B. Director Grant or award +7,377 7,423
2025-12-11 Siegel Jonathan B. Director Grant or award · Stock Option (right to buy) +7,377 7,377
2025-12-11 Jayasuriya Anula Director Grant or award +5,870 5,916
2025-12-11 Jayasuriya Anula Director Grant or award · Stock Option (right to buy) +5,870 5,870
2025-12-11 Lizak Carol R. Chief Financial Officer Grant or award +11,740 11,911
2025-12-11 Lizak Carol R. Chief Financial Officer Grant or award · Stock Option (right to buy) +11,740 11,740
2025-06-24 Siegel Jonathan B. Director Returned to the company · Convertible Promissory Note −9,000 $50,000.00 $450.0M 0
2025-06-24 Siegel Jonathan B. Director Grant or award · Convertible Promissory Note +9,462 $50,000.00 $473.1M 9,462

Page 1 of 10 · 185 trades